LESLIE FERRELL: Open Payments
NPI 1083878862 · GALATIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,573 in 85 payments from 15 companies in 2025. Trend: 2023 $2,096 · 2024 $2,025 · 2025 $1,573
Food & beverage: $1,573
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $287 |
| Lilly USA, LLC | 14 | $266 |
| GlaxoSmithKline, LLC. | 14 | $245 |
| Novo Nordisk Inc | 12 | $233 |
| ABBVIE INC. | 12 | $157 |
| Eisai Inc. | 3 | $93 |
| Phathom Pharmaceuticals, Inc. | 5 | $87 |
| Dexcom, Inc. | 2 | $48 |
| PFIZER INC. | 3 | $47 |
| Amgen Inc. | 2 | $28 |
Products named: MOUNJARO, TRELEGY ELLIPTA, Ozempic, FARXIGA, BREZTRI, Leqembi, VOQUEZNA, VRAYLAR.
Industry payments across IL — which companies pay providers there.
